Published December 19, 2022
| Version v1
Journal article
Open
Antibody Characterization Report for Spatacsin
Creators
- 1. Montreal Neurological Institute
- 2. Advanced BioImaging Facility (ABIF), McGill University
Description
Head-to-head comparison of available commercial antibodies against Spatacsin by immunoblot (Western blot), immunoprecipitation and immunofluorescence.
The following study was funded in part by Genome Québec's Genomics Integration Program, awarded to the research laboratory of Peter S. McPherson. This work was supported by the ALS-Reproducible Antibody Platform (ALS-RAP), a public-private partnership established by three prominent ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.
Files
Spatacsin_SPG11_YCharOS report.pdf
Files
(2.7 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:391c836f3bc594d4ffed167a31f59005
|
2.7 MB | Preview Download |